These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27389304)

  • 21. Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342--application to studies of antimalarial agents.
    Franklin RM; Brun R; Grieder A
    Z Parasitenkd; 1986; 72(2):201-12. PubMed ID: 2422821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds.
    Lucantoni L; Silvestrini F; Signore M; Siciliano G; Eldering M; Dechering KJ; Avery VM; Alano P
    Sci Rep; 2015 Nov; 5():16414. PubMed ID: 26553647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity.
    Hayase H; Watanabe N; Lim CL; Nogawa T; Komatsuya K; Kita K; Osada H
    Biosci Biotechnol Biochem; 2015; 79(4):633-5. PubMed ID: 25471083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
    Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.
    Abraham M; Gagaring K; Martino ML; Vanaerschot M; Plouffe DM; Calla J; Godinez-Macias KP; Du AY; Wree M; Antonova-Koch Y; Eribez K; Luth MR; Ottilie S; Fidock DA; McNamara CW; Winzeler EA
    ACS Infect Dis; 2020 Apr; 6(4):613-628. PubMed ID: 32078764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.
    Wirjanata G; Handayuni I; Prayoga P; Apriyanti D; Chalfein F; Sebayang BF; Kho S; Noviyanti R; Kenangalem E; Campo B; Poespoprodjo JR; Price RN; Marfurt J
    Malar J; 2015 Oct; 14():417. PubMed ID: 26498665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-lethal concentrations of artemisinin alter pH of the digestive vacuole of the malaria parasite, Plasmodium falciparum.
    Ibrahim N; Roslee A; Azlan M; Abu-Bakar N
    Trop Biomed; 2020 Mar; 37(1):1-14. PubMed ID: 33612713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum.
    Abu Bakar N; Klonis N; Hanssen E; Chan C; Tilley L
    J Cell Sci; 2010 Feb; 123(Pt 3):441-50. PubMed ID: 20067995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
    Nyakeriga AM; Perlmann H; Hagstedt M; Berzins K; Troye-Blomberg M; Zhivotovsky B; Perlmann P; Grandien A
    Microbes Infect; 2006 May; 8(6):1560-8. PubMed ID: 16702009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.
    Spicer T; Fernandez-Vega V; Chase P; Scampavia L; To J; Dalton JP; Da Silva FL; Skinner-Adams TS; Gardiner DL; Trenholme KR; Brown CL; Ghosh P; Porubsky P; Wang JL; Whipple DA; Schoenen FJ; Hodder P
    J Biomol Screen; 2014 Aug; 19(7):1107-15. PubMed ID: 24619116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-content live cell imaging with RNA probes: advancements in high-throughput antimalarial drug discovery.
    Cervantes S; Prudhomme J; Carter D; Gopi KG; Li Q; Chang YT; Le Roch KG
    BMC Cell Biol; 2009 Jun; 10():45. PubMed ID: 19515257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
    de Sousa ACC; Maepa K; Combrinck JM; Egan TJ
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.
    Kato N; March S; Bhatia SN; Marti M
    Methods Mol Biol; 2018; 1787():41-52. PubMed ID: 29736708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum.
    Ch'ng JH; Liew K; Goh AS; Sidhartha E; Tan KS
    Cell Death Dis; 2011 Oct; 2(10):e216. PubMed ID: 21993392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rab7 of Plasmodium falciparum is involved in its retromer complex assembly near the digestive vacuole.
    Siddiqui AA; Saha D; Iqbal MS; Saha SJ; Sarkar S; Banerjee C; Nag S; Mazumder S; De R; Pramanik S; Debsharma S; Bandyopadhyay U
    Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129656. PubMed ID: 32512169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs.
    Duffier Y; Lorthiois A; Cisteró P; Dupuy F; Jouvion G; Fiette L; Mazier D; Mayor A; Lavazec C; Moreno Sabater A
    Sci Rep; 2016 Oct; 6():35025. PubMed ID: 27731362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress and challenges in the use of fluorescence-based flow cytometric assays for anti-malarial drug susceptibility tests.
    Kulkeaw K
    Malar J; 2021 Jan; 20(1):57. PubMed ID: 33478496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2.
    Rosental B; Hadad U; Sinay R; Braiman A; Porgador A; Pollack Y
    Malar J; 2012 Nov; 11():371. PubMed ID: 23137170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.